title: Does topical ropivacaine reduce the post-tonsillectomy morbidity in pediatric patients?
abstract: OBJECTIVE
  To determine whether post-operative administration of topical ropivacaine hydrochloride decreases morbidity following adenotonsillectomy.
  
  
  METHODS
  Prospective, randomized, double-blind clinical trial.
  
  
  METHODS
  University referral center; ENT Department.
  
  
  METHODS
  Fourty one children, aged 4-16 years, undergoing tonsillectomy.
  
  
  METHODS
  Patients received 1.0% ropivacaine hydrochloride soaked swabs packed in their tonsillar fossae while the control group received saline-soaked swabs. Mc Grath's face scale was used to compare the two groups in respect of pain control. Chi-square and two-tailed unpaired Student's t-tests or Mann-Whitney-U-tests were used to compare the two independent groups. As 10 we made 11 comparison between groups, for Bonferroni correction, p<0.005 was accepted as statistically significant.
  
  
  RESULTS
  Only first hour there was no significant pain-relieving effect seen in the ropivacaine group (p>0.05). The other hours and days there were statistically significance between the two groups (p<0.001). Also, the other post-operative parameters such as nausea, fever, vomiting, odor, bleeding, otalgia and trismus were not statistically different between the two groups. There were no complications associated with ropivacaine hydrochloride. No patients in this study suffered systemic side effects related to the use of this medication.
  
  
  CONCLUSIONS
  Locally 1.0% ropivacaine administration significantly relieves the pain of pediatric tonsillectomy and, it is a safe and effective method. High concentrations of ropivaciane may produce clinically significant pain relief. It is more effective to reduce of post-operative analgesic requirement after first hour.
authors.affiliation: University of Dumlupinar, Training and Research Hospital, Department of Otorhinolaryngology and Head and Neck Surgery, Kutahya, Turkey. fatihoghan@hotmail.com
authors.forename: Fatih
authors.initials: F
authors.lastname: Oghan
authors.forename: Ugur
authors.initials: U
authors.lastname: Harputluoglu
authors.forename: Ender
authors.initials: E
authors.lastname: Guclu
authors.forename: Buket
authors.initials: B
authors.lastname: Kocaman
authors.forename: Ozcan
authors.initials: O
authors.lastname: Ozturk
mesh_terms: D000287:Administration, Topical; D000293:Adolescent; D000577:Amides / Q000008:administration & dosage / Q000627:therapeutic use*; D000779:Anesthetics, Local / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D010147:Pain Measurement; D010149:Postoperative Pain / Q000175:diagnosis / Q000188:drug therapy*; D011446:Prospective Studies; D000077212:Ropivacaine; D013997:Time Factors; D014068:Tonsillectomy
chemical_list: D000577:Amides; D000779:Anesthetics, Local; D000077212:Ropivacaine